Overview
The Scheduling of Drugs is the global classification system that determines which substances are legal, restricted, or criminalized.
It originates from the Convention on Psychotropic Substances (1971) which grouped compounds into four Schedules according to medical usefulness, potential for abuse, and public health risk.
What began as a technical framework for regulation became a moral taxonomy of consciousness, defining which altered states are legitimate and which are forbidden.
The UN Model
The Convention established four levels of control.
| Schedule | Principle | Examples |
|---|---|---|
| I | High abuse risk, little or no medical value | LSD, Psilocybin, DMT, Mescaline, MDMA |
| II | High abuse risk, some medical value | Amphetamine, Methamphetamine, Methylphenidate, PCP |
| III | Moderate risk, accepted medical use | Buprenorphine, Flunitrazepam, Pentobarbital, Cathine |
| IV | Low risk, broad medical use | Benzodiazepines, Barbiturates, Phenobarbital |
Use outside medicine or science is prohibited.
Production, possession, or trade without authorization must be treated as a punishable offence by all signatory states.
Translation into National Systems
Many countries mirrored this four-tier logic.
| Country/System | Structure | Notes |
|---|---|---|
| USA | Schedules I–V | Schedule I (LSD, heroin) = no accepted medical use, V = minimal control |
| UK | Classes A–C | Class A includes LSD and heroin, B covers stimulants, C covers sedatives |
| Switzerland / EU | Lists A–D | A = strictest (hallucinogens, opiates), D = over the counter |
The terminology differs, but the principle is the same, a graded scale of legitimacy based on perceived danger.
Cultural Logic
Scheduling controls more than chemistry, it controls meaning. By placing psychedelics together with narcotics in the most restricted category, the system equated non-addictive psychedelic states with compulsive drug dependence. The criteria were presented as scientific, yet the boundaries were cultural. A stimulant aiding productivity could be called medical, while a hallucinogen could be called abuse.
Article 32(4) of the 1971 Convention allowed countries to reserve traditional ritual use of plants like peyote or psilocybin mushrooms. This clause quietly admitted that not all use is abuse, but only within narrowly defined cultural contexts.
A ceremony in Mexico might be protected, the same act in London could be criminal.
Legality became tied not to chemistry, but to who uses it and why.
Each revision of scheduling, from LSD in 1971 to MDMA in 1986, repeated the same pattern.
A new substance appeared, culture reacted, law defined it through fear before evidence.
Once scheduled, reversal became nearly impossible.
Research remained theoretically legal, yet almost inaccessible.
Role of the US
The United States played a leading role in drafting and promoting the 1971 Convention.
Its delegation pushed for a global framework modeled on the new U.S. Controlled Substances Act, aiming to harmonize bans on LSD, amphetamines, and other synthetics. This effort aligned with the early War on Drugs, reflecting both health concerns and domestic pressure to curb the 1960s psychedelic culture and was likely motivate to close legal loopholes that would allowed production and export from abroad.